These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 15996865

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Axillary lymph node metastases as the sole clinical site of occult breast carcinoma.
    Dragoumis DM, Tsiftsoglou AP, Sikou AD, Assimaki AS.
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):517-9. PubMed ID: 18798593
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Metachronous secondary primary occult breast cancer initially presenting with metastases to the contralateral axillary lymph nodes: report of a case.
    Kinoshita S, Hirano A, Kobayashi S, Komine K, Kyoda S, Takeyama H, Uchida K, Morikawa T, Nagase J, Sakamoto G.
    Breast Cancer; 2010 Aug; 17(1):71-4. PubMed ID: 19259764
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Occult breast carcinoma presenting as an axillary mass.
    Scoggins CR, Vitola JV, Sandler MP, Atkinson JB, Frexes-Steed M.
    Am Surg; 1999 Jan; 65(1):1-5. PubMed ID: 9915521
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Occult breast cancer].
    Vasile D, Palade R, Voiculescu D.
    Chirurgia (Bucur); 1998 Jan; 93(4):247-53. PubMed ID: 9755574
    [Abstract] [Full Text] [Related]

  • 14. [Diagnosis and treatment of occult breast cancer in 44 cases].
    Lu S, Liu H.
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):550-2. PubMed ID: 22093638
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF, Patrick RJ, Rybicki LA, Hicks D, Weng DE, Crowe JP.
    Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN, Wijsman JH, Peterse JL, Rutgers EJ.
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.